Navigation Links
Arsenal Capital Partners übernimmt führendes Unternehmen für modellbasierte Arzneimittelentwicklung Certara
Date:12/20/2013

sentlichen Einfluss darauf haben."

Dr. James Rothman, dem 2013 der Nobelpreis für Physiologie oder Medizin zuerkannt wurde und der die Übernahme von Certara in seiner Rolle in der Healthcare Group von Arsenal Capital Partners prüfte, erklärte, dass das Interesse von Arsenal an der Übernahme in der Fähigkeit von Certara, sowohl die Effektivität als auch die Effizienz des Arzneimittelentwicklungsprozesses zu verbessern, begründet liege. „Die modellbasierte Arzneimittelentwicklung ermöglicht es Pharma- und Biotechnologieunternehmen, einen rigoroseren, quantitativen Ansatz bei der Arzneimittelentwicklung zu verfolgen. Dies führt dazu, dass mehr Entscheidungen in voller Kenntnis einer Sachlage getroffene werden können, wenn es darum geht, für welche Arzneimittelkandidaten der Prozess fortgesetzt wird und wie der Aufbau von klinischen Studien optimiert werden kann, was für die Industrie und letztendlich für die Patienten von Vorteil ist", erklärte Dr. Rothman, zukünftiges Mitglied des Vorstands von Certara.

„Arsenal teilt unsere Vision, Analyseinstrumente und wissenschaftliche Informatik anzuwenden, um eine verbesserte Verbreitung pharmazeutischen Wissens zu erreichen. Nach sorgfältiger Prüfung waren wir vom präzisen Verständnis unserer Mission und unseres Werts durch Arsenal beeindruckt. Wir sind der Überzeugung, dass dies die richtige Wahl für Certara ist und sowohl zum Vorteil unserer Kunden als auch unserer Mitarbeiter sein wird", erklärte Jim Hopkins, CEO von Certara.

Dr. Donald A. Deieso, Operating Partner und Co-Head der Healthcare Group von Arsenal erklärte: „Die Aufnahme von Certara in unser Unternehmensportfolio stärkt unseren Fokus auf die Bereitstellung von Lösungen für die
'/>"/>

SOURCE Arsenal Capital Partners
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Arsenal Capital Partners verwerft Certara, leider in geneesmiddelontwikkeling op basis van modellen
2. Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
3. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
4. UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
5. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
6. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
7. S&P Capital IQ to Share Its Views on the Biotech Bull Market During the Next "ETF Analyst Hour"
8. Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing
9. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
10. GW Pharmaceuticals to Present at the 2013 Aegis Capital Healthcare Conference
11. Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") ... active control Phase 3 study of Zerenex (ferric citrate), ... the treatment of hyperphosphatemia in patients with end-stage renal ... and iRon delivery with FErric CiTrate in EsrD) was ... American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... MESA, Calif. , July 24, 2014  Now ... close to home. Rehealth Regenerative Therapies , located ... athletes and other physically active people a new health ... Regardless of age, countless patients suffer from ... sport activities, such as muscle tears, torn rotator cuff, ...
(Date:7/24/2014)... trained personnel, and detection dogs to safeguard airports ... revolutionary new electronic chip with nano-sized chemical sensors ... , The groundbreaking nanotechnology-inspired sensor, devised by Prof. ... of Chemistry and Center for Nanoscience and Nanotechnology, ... up the scent of explosives molecules better than ...
(Date:7/24/2014)... Engineering at the University of Delaware, is known ... energy engineering, environmental sustainability and electronics. , His ... with a well-defined, crystalline structure. At the atomic ... that zeolites can separate molecules with size differences ... of a nanometer), making them useful to the ...
Breaking Biology Technology:Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Nano-sized chip 'sniffs out' explosives far better than trained dogs 2University of Delaware researcher describes new approach for creating organic zeolites 2
... Researcher Appreciation Event ... ... PHOENIX, Oct. 3 ThirdBiotech Inc., http://www.thirdbiotech.com, a biotechnology incubator ... Appreciation Event to be held on Thursday, October 23rd, 2008,between noon and ...
... http://www.amdl.com ),AMDL, Inc. (Amex: ADL ), a leading ... the US, today announced that the,Company will present at ... on Tuesday, October 7, 2008 at 10:30 a.m. ET. ... York Hotel in the Morosco Room., The Maxim ...
... Support R&D Efforts and Clinical Trials Advancing,the ... Oct. 3 Micromet, Inc. (Nasdaq:,MITI) ("Micromet" ... proprietary antibodies for the treatment of cancer, ... has closed its previously,announced $40 million private ...
Cached Biology Technology:First Annual Arizona Biotech Day Announced for October 23rd 2008 2First Annual Arizona Biotech Day Announced for October 23rd 2008 3AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 3Micromet Closes $40 Million Private Equity Placement 2Micromet Closes $40 Million Private Equity Placement 3Micromet Closes $40 Million Private Equity Placement 4
(Date:7/25/2014)... is a complex congenital central nervous system disease ... the neural tubes during the embryonic phase. Many ... fecal incontinence and neurocognitive retardation. Such problems decrease ... life. Researchers at Ankara Physical Medicine and Rehabilitation ... performance in children with SB, using the Pediatric ...
(Date:7/25/2014)... girls reach puberty is influenced by ,imprinted genes,a subset of ... gene. This is the first evidence that imprinted genes ... of this study were published today in the journal ... menarche, is a marker for the timing of puberty in ... varies between girls, is an inherited trait, and is linked ...
(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3
... European College of Neuropsychopharmacology (ECNP) is pleased to ... 2009 ECNP Neuropsychopharmacology Award in Basic Science Research ... into the neurochemical basis of substance addiction. ... in the field of neuropsychopharmacology and its closely ...
... Researchers have made significant advances in the treatment of metastatic ... treat successfully once it has started to spread according ... congress, ECCO 15 ESMO 34 [1], in Berlin on ... seen rapid and dramatic shrinking of metastatic tumours in patients ...
... research team at the National Institute of Standards and ... possible cancer therapy has uncovered a delicate balancing act ... says they should be. Just like individuals in a ... because they get close together, but not too close. ...
Cached Biology News:Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 2Trial of new treatment for advanced melanoma shows rapid shrinking of tumors 3Therapeutic nanoparticles give new meaning to sugar-coating medicine 2
... Imaging System is the cost-effective solution for ... tailored to common research imaging tasks, MetaVue ... and simple image analysis. Compatibility with ... means that MetaVue has the power to ...
Sterile, Cell culture tested...
... Although there have been many modifications to ... defined media, salt solutions still play an important ... to maintain the pH and osmotic balance in ... water and essential inorganic ions, is as valuable ...
A substrate for all AChE-based EIA kits....
Biology Products: